Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000312

Drug Information
NameRemoxipride
Synonyms(-)-(S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide; A 33547; Remoxipride (USAN); AC1Q2696; 80125-14-0; AB00514647; Prestwick3_000971; NCGC00024870-02; BRD-K54094468-003-03-8; (-)-n-ethyl-2-(3-bromo-2,6-dimethoxybenzamidomethyl)pyrrolidine; NCGC00024870-01; (S)-3-Bromo-2,6-dimethoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide; Remoxipridum; CAS-73220-03-8; BPBio1_001171; 73220-03-8 (mono-hydrochloride); BRD-K54094468-001-01-6; (-)-(S)-3-Brom-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamid; A-33547; Prestwick1_000971; SPBio_002912; Biomol-NT_000015; Remoxiprida; BPBio1_001103; Tocris-0916; Benzamide, 3-bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxy-, (S)-; (S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide; LS-25856; Romoxipride; CHEMBL22242; DB00409; NCGC00016921-01; Prestwick0_000971; Remoxipride [USAN:BAN:INN]; Prestwick2_000971; BRN 4323708; 3-bromo-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2,6-dimethoxybenzamide; Remoxipridum [INN-Latin]; BSPBio_001001; 117591-79-4 (mono-hydrochloride monohydrate); Benzamide, 3-bromo-2,6-dimethoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)-, (S)-; D02682; FLA 731; FLA-731; HMS2089L19; CHEBI:127616; Remoxiprida [INN-Spanish]; UNII-0223RD59PE; Remoxipride; MolPort-003-666-824; NCGC00024870-03; CID54477; AC1L1H2R
IndicationSchizophrenia
[ICD9: 295   ICD10: F20]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12
(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1
InChIKeyGUJRSXAPGDDABA-NSHDSACASA-N
Canonical SMILESCCN1CCCC1CNC(=O)C2=C(C=CC(=C2OC)Br)OC    
Isomeric SMILESCCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2OC)Br)OC
Therapeutic ClassAntipsychotic Agents
CAS NumberCAS 80125-14-0
FormulaC16H23BrN2O3
PubChem Compound IDCID 54477.
PubChem Substance IDSID 192058.
SuperDrug ATC IDN05AL04
SuperDrug CAS ID080125140;
TargetD(2) dopamine receptorAntagonist[2][3]
Ref 1The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31. To Reference
Ref 2Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27-38. To Reference
Ref 3Remoxipride in Parkinson's disease: differential response in patients with dyskinesias fluctuations versus psychosis. Clin Neuropharmacol. 1995 Feb;18(1):39-45. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543